Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.7500
-0.1500 (-16.67%)
At close: Sep 4, 2026
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $5.36 million as of September 4, 2026. Its market cap has decreased by -37.69% in one year.
Market Cap
5.36M
Enterprise Value
8.81M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
ChartMarket Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.35M to 5.36M, a decrease of -76.00%. That is a compound annual growth rate of -7.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 5.36M | -7.41% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Institute of Biomedical Research | 8.23M |
| Hepion Pharmaceuticals | 7.94M |
| OSR Health | 7.90M |
| Adaptimmune Therapeutics | 7.10M |
| Reviva Pharmaceuticals Holdings | 6.95M |
| TRON Group | 5.52M |
| America Great Health | 5.29M |
| Pacific Software | 4.98M |